HK Stock Market Move | H&H INTL HLDG (01112) rose over 3% intraday. The health supplement industry is expected to see continued catalysts, and Swisse's leading position remains solid.

H&H INTL HLDG (01112) rose over 3% intraday. As of press time, it was up 2.61% at HK$20.42, with a turnover of HK$37.0026 million. The Pacific Securities pointed out that rising health awareness among younger demographics and improving health consumption sentiment are expected to bring continued catalysts to the health supplement industry. Public information shows that H&H INTL HLDG's Swisse brand, positioned around "nature + scientific nutrition," has built a full life-cycle matrix and has become the No. 1 health supplement brand in mainland China and Australia. Guotai Haitong issued a research report, initiating coverage on H&H INTL HLDG with an "Overweight" rating. It estimates the company's EPS for 2026-2028 to be RMB 1.63/1.88/2.04. Considering that the company is gradually reducing debt and the proportion of its health supplement business continues to rise, under the resonance of an upward business performance cycle and improving debt cycle, the company is expected to usher in a revaluation. The initial coverage gives the company an 18x PE for 2026, corresponding to a target price of HK$34.12.